DOCSLIB.ORG

Syn3 Gene Knockout Negatively Impacts Aspects of Reversal Learning Performance

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Syn3 Gene Knockout Negatively Impacts Aspects of Reversal Learning Performance Research Article: New Research | Cognition and Behavior Syn3 gene knockout negatively impacts aspects of reversal learning performance https://doi.org/10.1523/ENEURO.0251-21.2021 Cite as: eNeuro 2021; 10.1523/ENEURO.0251-21.2021 Received: 4 June 2021 Revised: 4 August 2021 Accepted: 15 August 2021 This Early Release article has been peer-reviewed and accepted, but has not been through the composition and copyediting processes. The final version may differ slightly in style or formatting and will contain links to any extended data. Alerts: Sign up at www.eneuro.org/alerts to receive customized email alerts when the fully formatted version of this article is published. Copyright © 2021 Moore et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. Manuscript Title: Syn3 gene knockout negatively impacts aspects of reversal learning performance Abbreviated Title: Syn3 regulates behavioral flexibility Authors: Alyssa Moore, Department of Psychology, Binghamton University, Binghamton, NY 13902 Jérôme Linden, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles CA 90095 James D. Jentsch, Department of Psychology, Binghamton University, Binghamton, NY 13902 Author Contributions: JDJ and JL designed research; JL and AM performed research; AM analyzed data; AM and JDJ wrote the paper Correspondence should be addressed to: J. David Jentsch, Department of Psychology, State University of New York at Binghamton, Binghamton NY, 13902. Email: [email protected] Conflict of Interest: Authors report no conflict of interest Funding Sources: These studies were supported, in part, by Public Health Service grants R21- DA038377 (JDJ), T32-AA025606 (JDJ and AM) and P50-DA039841 (JDJ). 1 1 2 Abstract 3 Behavioral flexibility enables the ability to adaptively respond to changes in contingency 4 requirements to maintain access to desired outcomes, and deficits in behavioral flexibility have been 5 documented in many psychiatric disorders. Previous research has shown a correlation between 6 behavioral flexibility measured in a reversal learning test and Syn3, the gene encoding synapsin III, which 7 negatively regulates phasic dopamine release. Syn3 expression in the hippocampus, striatum, and 8 neocortex is reported to be negatively correlated with reversal learning performance, so here, we 9 utilized a global knockout line to investigate reversal learning in mice homozygous wildtype, 10 heterozygous null, and homozygous null for the Syn3 gene. Compared to wildtype animals, we found a 11 reversal specific effect of genetic Syn3 deficiency that resulted in a greater proportional increase in trials 12 required to reach a preset performance criteria during contingency reversal, despite no observed 13 genotype effects on the ability to acquire the initial discrimination. Behavioral flexibility scores, which 14 quantified the likelihood of switching subsequent choice behavior following positive or negative 15 feedback, became significantly more negative in reversal only for Syn3 homozygous null mice, 16 suggesting a substantial increase in perseverative behavior in the reversal phase. Syn3 ablation reduced 17 the number of anticipatory responses made per trial, often interpreted as a measure of waiting 18 impulsivity. Overall, Syn3 expression negatively affected behavioral flexibility in a reversal specific 19 manner but may have reduced waiting impulsivity. 20 2 21 Significance Statement 22 Adaptations to changes in the environment are facilitated by behavioral flexibility, and inflexible 23 behavior is observed in several mental health disorders. The Syn3 gene encodes synapsin III, a protein 24 that negatively regulates phasic dopamine release by sequestering vesicles away from the ready- 25 releasable pool. Previous research has shown a positive genetic correlation between Syn3 expression in 26 brain and behavioral flexibility in a reversal learning task. Here, we show that mice carrying null alleles 27 of the Syn3 gene exhibit less flexible responding following contingency reversal. These data reveal novel 28 information about genetic mechanisms that may contribute to the impaired flexibility observed in 29 multiple psychiatric conditions. 30 3 31 Introduction 32 Behavioral flexibility relates to an individual’s ability to modify behavioral patterns in changing 33 environmental conditions. Deficits in behavioral flexibility have been characterized in several 34 psychiatric disorders (Uddin, 2021), including schizophrenia (Waltz, 2017; Waltz & Gold, 2007), autism 35 spectrum disorder (Kelly & Reed, 2020), obsessive-compulsive disorder (Gruner & Pittenger, 2017; 36 Vaghi et al., 2017), and substance use disorders (Winstanley et al., 2010; Isten et al., 2017; Robbins et 37 al., 2012; Ersche et al., 2010). 38 Reversal learning is an operant test of behavioral flexibility in which an initial association 39 (stimulus-response or response-outcome) is learned through reinforcement, before the conditions for 40 reinforcement are reversed and the organism is tested for its ability to update behavior (Izquierdo et 41 al., 2017, Izquierdo & Jentsch, 2012). In other words, one response is established as prepotent during 42 initial acquisition through positive feedback and must then be inhibited or changed during reversal 43 testing to procure reward. 44 Laughlin et al. (2011) evaluated reversal learning in a panel of BXD mouse strains and utilized a 45 genome-wide linkage approach to model the impact of genetic variation on the reversal phenotype. A 46 genome-wide quantitative trait locus on mouse chromosome 10 was identified, and Syn3, the gene 47 encoding synapsin III, emerged as a positional candidate expressed from that genomic region. Syn3 48 mRNA expression is regulated in cis, and its expression in the hippocampus, neocortex, and striatum 49 was found to be positively genetically correlated with reversal learning performance in the BXD panel, 50 such that greater Syn3 expression associated with faster reversal learning (Laughlin et al., 2011). 51 Synapsin III is a member of the synapsin family of neuronal phosphoproteins (Kao et al., 1998). 52 Synapsin III can be localized on the cytoplasmic side of synaptic vesicles and is implicated in 53 neurotransmitter release. Feng and colleagues (2002) demonstrated loss of synapsin III led to larger 54 vesicular recycling pools but did not alter vesicular release or quantal dynamics. Synapsin proteins 4 55 regulate a distal reserve pool of vesicles (Greengard et al., 1993; Hilfiker et al., 1999; Hilfiker et al., 56 2005). Functionally, a loss of synapsin III prevents vesicles from being sequestered away from the 57 ready-releasable pool, promoting more sustained release during continued stimulation. In a typical 58 case, sustained release is limited by the rate of transfer of vesicles from the reserve pool to the active 59 zone; this rate-limiting process is theoretically disrupted in cells lacking synapsin III as vesicles are 60 inadequately sequestered in the reserve. 61 Synapsins are differentially expressed in neuronal populations. Bogen and colleagues (2006) 62 found selective deletion of synapsin I and II substantially reduced vesicular uptake of GABA and 63 glutamate but did not alter dopamine (DA) uptake. Deletion reduced concentration of vesicular 64 transporters related to glutamate and gamma-aminobutyric acid (GABA), but not vesicular monoamine 65 transporter 2 (VMAT2), the transporter responsible for packaging dopamine. Further, synapsin I and II 66 colocalized in cells expressing vesicular transporters for GABA and glutamate, but not in dopaminergic 67 terminals. A subsequent study utilized a triple knock-out approach to investigate differential regulation 68 of dopamine and serotonin by synapsins (Kile et al., 2010): serotonin was not altered by deletion of all 69 three synapsins, but DA release was significantly enhanced. Selective deletion of synapsin III also 70 elicited enhanced DA release, demonstrating a distinct role for the synapsins in regulating 71 neurotransmitter release. Because DA is extensively implicated in neuropsychiatric disorders, 72 subcellular proteins which contribute to dopamine dynamics and the genes encoding them are of 73 interest. 74 The action of dopamine on its cognate receptors in corticostriatal systems are functionally 75 implicated in behavioral flexibility and reversal learning. Inactivation of the D1-mediated direct 76 pathway of the basal ganglia interfered with the acquisition of novel and reversed contingencies, while 77 inactivation of the D2-mediated indirect pathway interfered selectively with reversal performance by 78 increasing perseverative errors (Yawata et al. 2012). Selective deletion of presynaptic D2 receptors 5 79 also tended to impair reversal performance and increased the number of attempts required to 80 complete a sustained observing response to initiate a trial (Linden et al., 2018), a deficit related to 81 waiting impulsivity (Dalley & Ersche, 2019). Groman et al (2011) found that D2 receptor availability in 82 the caudate and putamen of vervet monkeys was correlated with reversal learning performance and 83 sensitivity to positive feedback. In a study examining DA in a compulsivity-relevant behavioral 84 phenotype, Barker et al. (2014) found that inhibiting D1 or activating D2 in the infralimbic
Load more

Recommended publications
  • 1 Evidence for Gliadin Antibodies As Causative Agents in Schizophrenia
    1 Evidence for gliadin antibodies as causative agents in schizophrenia. C.J.Carter PolygenicPathways, 20 Upper Maze Hill, Saint-Leonard’s on Sea, East Sussex, TN37 0LG [email protected] Tel: 0044 (0)1424 422201 I have no fax Abstract Antibodies to gliadin, a component of gluten, have frequently been reported in schizophrenia patients, and in some cases remission has been noted following the instigation of a gluten free diet. Gliadin is a highly immunogenic protein, and B cell epitopes along its entire immunogenic length are homologous to the products of numerous proteins relevant to schizophrenia (p = 0.012 to 3e-25). These include members of the DISC1 interactome, of glutamate, dopamine and neuregulin signalling networks, and of pathways involved in plasticity, dendritic growth or myelination. Antibodies to gliadin are likely to cross react with these key proteins, as has already been observed with synapsin 1 and calreticulin. Gliadin may thus be a causative agent in schizophrenia, under certain genetic and immunological conditions, producing its effects via antibody mediated knockdown of multiple proteins relevant to the disease process. Because of such homology, an autoimmune response may be sustained by the human antigens that resemble gliadin itself, a scenario supported by many reports of immune activation both in the brain and in lymphocytes in schizophrenia. Gluten free diets and removal of such antibodies may be of therapeutic benefit in certain cases of schizophrenia. 2 Introduction A number of studies from China, Norway, and the USA have reported the presence of gliadin antibodies in schizophrenia 1-5. Gliadin is a component of gluten, intolerance to which is implicated in coeliac disease 6.
    [Show full text]
  • Downloaded from the National Database for Autism Research (NDAR)
    International Journal of Molecular Sciences Article Phenotypic Subtyping and Re-Analysis of Existing Methylation Data from Autistic Probands in Simplex Families Reveal ASD Subtype-Associated Differentially Methylated Genes and Biological Functions Elizabeth C. Lee y and Valerie W. Hu * Department of Biochemistry and Molecular Medicine, The George Washington University, School of Medicine and Health Sciences, Washington, DC 20037, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-202-994-8431 Current address: W. Harry Feinstone Department of Molecular Microbiology and Immunology, y Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Received: 25 August 2020; Accepted: 17 September 2020; Published: 19 September 2020 Abstract: Autism spectrum disorder (ASD) describes a group of neurodevelopmental disorders with core deficits in social communication and manifestation of restricted, repetitive, and stereotyped behaviors. Despite the core symptomatology, ASD is extremely heterogeneous with respect to the severity of symptoms and behaviors. This heterogeneity presents an inherent challenge to all large-scale genome-wide omics analyses. In the present study, we address this heterogeneity by stratifying ASD probands from simplex families according to the severity of behavioral scores on the Autism Diagnostic Interview-Revised diagnostic instrument, followed by re-analysis of existing DNA methylation data from individuals in three ASD subphenotypes in comparison to that of their respective unaffected siblings. We demonstrate that subphenotyping of cases enables the identification of over 1.6 times the number of statistically significant differentially methylated regions (DMR) and DMR-associated genes (DAGs) between cases and controls, compared to that identified when all cases are combined. Our analyses also reveal ASD-related neurological functions and comorbidities that are enriched among DAGs in each phenotypic subgroup but not in the combined case group.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supplementary Table 3 Complete List of RNA-Sequencing Analysis of Gene Expression Changed by ≥ Tenfold Between Xenograft and Cells Cultured in 10%O2
    Supplementary Table 3 Complete list of RNA-Sequencing analysis of gene expression changed by ≥ tenfold between xenograft and cells cultured in 10%O2 Expr Log2 Ratio Symbol Entrez Gene Name (culture/xenograft) -7.182 PGM5 phosphoglucomutase 5 -6.883 GPBAR1 G protein-coupled bile acid receptor 1 -6.683 CPVL carboxypeptidase, vitellogenic like -6.398 MTMR9LP myotubularin related protein 9-like, pseudogene -6.131 SCN7A sodium voltage-gated channel alpha subunit 7 -6.115 POPDC2 popeye domain containing 2 -6.014 LGI1 leucine rich glioma inactivated 1 -5.86 SCN1A sodium voltage-gated channel alpha subunit 1 -5.713 C6 complement C6 -5.365 ANGPTL1 angiopoietin like 1 -5.327 TNN tenascin N -5.228 DHRS2 dehydrogenase/reductase 2 leucine rich repeat and fibronectin type III domain -5.115 LRFN2 containing 2 -5.076 FOXO6 forkhead box O6 -5.035 ETNPPL ethanolamine-phosphate phospho-lyase -4.993 MYO15A myosin XVA -4.972 IGF1 insulin like growth factor 1 -4.956 DLG2 discs large MAGUK scaffold protein 2 -4.86 SCML4 sex comb on midleg like 4 (Drosophila) Src homology 2 domain containing transforming -4.816 SHD protein D -4.764 PLP1 proteolipid protein 1 -4.764 TSPAN32 tetraspanin 32 -4.713 N4BP3 NEDD4 binding protein 3 -4.705 MYOC myocilin -4.646 CLEC3B C-type lectin domain family 3 member B -4.646 C7 complement C7 -4.62 TGM2 transglutaminase 2 -4.562 COL9A1 collagen type IX alpha 1 chain -4.55 SOSTDC1 sclerostin domain containing 1 -4.55 OGN osteoglycin -4.505 DAPL1 death associated protein like 1 -4.491 C10orf105 chromosome 10 open reading frame 105 -4.491
    [Show full text]
  • Identification of a Mutation in Synapsin I, a Synaptic Vesicle Protein, in a Family with Epilepsy J Med Genet: First Published As on 1 March 2004
    183 SHORT REPORT Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy J Med Genet: first published as on 1 March 2004. Downloaded from C C Garcia, H J Blair, M Seager, A Coulthard, S Tennant, M Buddles, A Curtis, J A Goodship ............................................................................................................................... J Med Genet 2004;41:183–187. doi: 10.1136/jmg.2003.013680 hippocampal bodies are moderately atrophic but without A four generation family is described in which some men of signal intensities. normal intelligence have epilepsy and others have various III-2 is a 64 year old man who has had a cerebrovascular combinations of epilepsy, learning difficulties, macrocephaly, accident but was previously of normal intelligence. He had and aggressive behaviour. As the phenotype in this family is tonic-clonic seizures until aged 7. His head circumference is distinct from other X linked recessive disorders linkage studies normal. were carried out. Linkage analysis was done using X III-3 is a 53 year old man with a full scale IQ that has been chromosome microsatellite polymorphisms to define the formally assessed as 72 (with the recognised error in such interval containing the causative gene. Genes from within assessments this places him within the borderline to mild the region were considered possible candidates and one of learning difficulties range). His head circumference is these, SYN1, was screened for mutations by direct DNA normal. As a teenager, he showed extreme physical aggres- sequencing of amplified products. Microsatellite analysis sion (he was held in a high security psychiatric hospital showed that the region between MAOB (Xp11.3) and between the ages of 11 and 18).
    [Show full text]
  • Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering After Endocytosis
    Neuron Article Increased Expression of a-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis Venu M. Nemani,1 Wei Lu,2 Victoria Berge,3 Ken Nakamura,1 Bibiana Onoa,1 Michael K. Lee,4 Farrukh A. Chaudhry,3 Roger A. Nicoll,2 and Robert H. Edwards1,* 1Departments of Neurology and Physiology, Graduate Program in Neuroscience 2Department of Cellular and Molecular Pharmacology University of California, San Francisco, San Francisco, CA 94158, USA 3The Biotechnology Centre of Oslo, Centre for Molecular Biology and Neuroscience, University of Oslo, Oslo, Norway 4Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA *Correspondence: [email protected] DOI 10.1016/j.neuron.2009.12.023 SUMMARY Parkinson’s disease (PD) and Lewy body dementia (LBD) (Spill- antini et al., 1998; Dickson, 2001). Point mutations in asyn are The protein a-synuclein accumulates in the brain of also linked to an autosomal-dominant form of PD (Polymeropou- patients with sporadic Parkinson’s disease (PD), los et al., 1997; Kru¨ ger et al., 1998; Zarranz et al., 2004). Taken and increased gene dosage causes a severe, domi- together, these observations suggest a causative role for asyn nantly inherited form of PD, but we know little about in sporadic as well as inherited PD and LBD. In addition, duplica- the effects of synuclein that precede degeneration. tion and triplication of the asyn gene suffice to cause a severe, a-Synuclein localizes to the nerve terminal, but the highly penetrant form of PD (Singleton et al., 2003; Chartier- Harlin et al., 2004), and polymorphisms in regulatory elements knockout has little if any effect on synaptic transmis- of the asyn gene predispose to PD (Maraganore et al., 2006), sion.
    [Show full text]
  • A Novel Method of Neural Differentiation of PC12 Cells by Using Opti-MEM As a Basic Induction Medium
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 41: 195-201, 2018 A novel method of neural differentiation of PC12 cells by using Opti-MEM as a basic induction medium RENDONG HU1*, QIAOYU CAO2*, ZHONGQING SUN3, JINYING CHEN4, QING ZHENG2 and FEI XIAO1 1Department of Pharmacology, School of Medicine, Jinan University; 2College of Pharmacy, Jinan University, Guangzhou, Guangdong 510632; 3Department of Anesthesia and Intensive Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong 999077, SAR; 4Department of Ophthalmology, The First Clinical Medical College of Jinan University, Guangzhou, Guangdong 510632, P.R. China Received April 5, 2017; Accepted October 11, 2017 DOI: 10.3892/ijmm.2017.3195 Abstract. The PC12 cell line is a classical neuronal cell model Introduction due to its ability to acquire the sympathetic neurons features when deal with nerve growth factor (NGF). In the present study, The PC12 cell line is traceable to a pheochromocytoma from the authors used a variety of different methods to induce PC12 the rat adrenal medulla (1-4). When exposed to nerve growth cells, such as Opti-MEM medium containing different concen- factor (NGF), PC12 cells present an observable change in trations of fetal bovine serum (FBS) and horse serum compared sympathetic neuron phenotype and properties. Neural differ- with RPMI-1640 medium, and then observed the neurite length, entiation of PC12 has been widely used as a neuron cell model differentiation, adhesion, cell proliferation and action poten- in neuroscience, such as in the nerve injury-induced neuro- tial, as well as the protein levels of axonal growth-associated pathic pain model (5) and nitric oxide-induced neurotoxicity protein 43 (GAP-43) and synaptic protein synapsin-1, among model (6).
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Selective Lowering of Synapsins Induced by Oligomeric Α-Synuclein Exacerbates Memory Deficits
    Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits Megan E. Larsona,b,c,1, Susan J. Greimela,b,c,1, Fatou Amara,b,c, Michael LaCroixa,b,c, Gabriel Boylea,b,c, Mathew A. Shermana,b,c, Hallie Schleya,b,c, Camille Miela,b,c, Julie A. Schneiderd, Rakez Kayede, Fabio Benfenatif,g, Michael K. Leea,c, David A. Bennettd, and Sylvain E. Lesnéa,b,c,2 aDepartment of Neuroscience, University of Minnesota, Minneapolis, MN 55414; bN. Bud Grossman Center for Memory Research and Care, University of Minnesota, Minneapolis, MN 55414; cInstitute for Translational Neuroscience, University of Minnesota, Minneapolis, MN 55414; dRush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL 60612; eDepartment of Neurology, University of Texas Medical Branch, Galveston, TX 77555; fCenter for Synaptic Neuroscience, Istituto Italiano di Tecnologia, 16132 Genoa, Italy; and gDepartment of Experimental Medicine, University of Genova, 16132 Genoa, Italy Edited by Solomon H. Snyder, The Johns Hopkins University School of Medicine, Baltimore, MD, and approved April 24, 2017 (received for review April 4, 2017) Mounting evidence indicates that soluble oligomeric forms of a reduction in the synaptic vesicle recycling pool, and a selective amyloid proteins linked to neurodegenerative disorders, such as lowering of complexins and synapsins (8). Moreover, large mul- amyloid-β (Aβ), tau, or α-synuclein (αSyn) might be the major del- timeric assemblies of recombinant αSyn were recently shown to eterious species for neuronal function in these diseases. Here, we inhibit exocytosis by preferentially binding to synaptobrevin, found an abnormal accumulation of oligomeric αSyn species in AD thereby preventing normal SNARE-mediated vesicle docking (9).
    [Show full text]
  • Cardiac Arrhythmia After Myocardial Infarction
    CARDIAC ARRHYTHMIA AFTER MYOCARDIAL INFARCTION: INSIGHTS FROM A DYNAMIC CANINE VENTRICULAR MYOCYTE MODEL by Thomas J. Hund Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Thesis Advisor: Dr. Yoram Rudy Department of Biomedical Engineering CASE WESTERN RESERVE UNIVERSITY May 2004 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ______________________________________________________ candidate for the Ph.D. degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. For Keila iii TABLE OF CONTENTS List of Tables ...................................................................................................................... 3 List of Figures..................................................................................................................... 4 Acknowledgments............................................................................................................... 6 List of Abbreviations .......................................................................................................... 7 Glossary .............................................................................................................................
    [Show full text]
  • Post-Transcriptional Regulation of Synaptic Vesicle Protein Expression and the Developmental Control of Synaptic Vesicle Formation
    The Journal of Neuroscience, April 1, 1997, 17(7):2365–2375 Post-Transcriptional Regulation of Synaptic Vesicle Protein Expression and the Developmental Control of Synaptic Vesicle Formation Christopher Daly and Edward B. Ziff Department of Biochemistry, Howard Hughes Medical Institute, New York University Medical Center, New York, New York 10016 The regulated expression of synaptic vesicle (SV) proteins dur- synaptophysin synthesis is not simply the result of an increase ing development and the assembly of these proteins into func- in mRNA level, but is largely attributable to an increase in the tional SVs are critical aspects of nervous system maturation. rate of translational initiation. Despite the nearly constant rates We have examined the expression patterns of four SV proteins of synthesis of synaptotagmin I, vamp 2, and synapsin I, we in embryonic hippocampal neurons developing in culture and show that the number of SVs in these developing neurons have found that increases in the levels of these proteins result increases, and that SV proteins are more efficiently targeted to primarily from post-transcriptional regulation. Synaptotagmin I, SVs at later times in culture. Our results suggest that SV vamp 2, and synapsin I proteins are synthesized at nearly production during development is not limited by the rates of constant rates as the neurons develop. However, these pro- transcription of genes encoding the component proteins, thus teins are relatively unstable at early times in culture and un- allowing control of this process by cytoplasmic mechanisms, dergo a progressive increase in half-life with time, possibly as a without signaling to the nucleus.
    [Show full text]
  • Synapsin I in PC1 2 Cells. I. Characterization of the Phosphoprotein and Effect of Chronic NGF Treatment
    The Journal of Neuroscience, May 1987, 7(5): 1294-l 299 Synapsin I in PC1 2 Cells. I. Characterization of the Phosphoprotein and Effect of Chronic NGF Treatment Carmelo Romano, Robert A. Nichols, Paul Greengard, and Lloyd A. Greene Laboratory of Molecular and Cellular Neuroscience, Rockefeller University, New York, New York 10021; and Department of Pharmacology, New York University School of Medicine, New York, New York 10016 PC1 2 cells contain a synapsin l-like molecule. Several serum Adrenal chromaffin cells and sympathetic neurons share a and monoclonal antibodies raised against bovine brain syn- neural crest origin and many other similarities (Coupland, 1965; apsin I bind to and precipitate this molecule, demonstrating Weston, 1970). Nevertheless, normal rat adrenal chromaffin immunochemical similarity between the brain and PC12 cells do not, whereassympathetic neurons do, contain synapsin species. PC12 synapsin I, like brain synapsin I, is a phos- I (DeCamilli et al., 1979; Fried et al., 1982). To better under- phoprotein: It is phosphorylated in intact cells and, when stand the developmental regulation of synapsin I, it was there- partially purified, serves as a substrate for several synapsin fore of interest to study synapsin I in PC 12 cells and its possible I kinases. PC1 2 cell synapsin I is structurally similar to brain alteration upon treatment of the cells with NGF. This paper synapsin I as shown by peptide mapping of %-methionine- characterizes the synapsin I present in PC12 cells and demon- and 32P-phosphate-labeled molecules from the 2 sources. strates effects of long-term NGF treatment of the cells on the Chronic NGF treatment of the cells induces a significant phosphoprotein.The accompanyingpaper (Roman0 et al., 1987) increase in the amount of synapsin I relative to total cell demonstratesthat short-term NGF treatment of PC12 cells re- protein, measured either by immunolabeling or incorporation sults in the phosphorylation of synapsin I at a novel site.
    [Show full text]